Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Critical Mediators of Multiple Sclerosis Disease Suppression. Edition No. 1

VDM Publishing House, June 2009, Pages: 120


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Multiple sclerosis (MS) is a chronic demyelinating
disease of the CNS affecting nearly 3 million people
world-wide. Patients present with a myriad of
symptoms making MS difficult to diagnose. Clinical
presentation of MS ranges from mild to severe, and
no two patients can be said to demonstrate the same
clinical course. Females are three times as likely
as males to be affected, but males often present
with a more severe disease course. Pregnancy
suppresses MS severity in human and animal models.
This is likely due to hormone and genetics
regulation of proteins involved with inflammation
such as PI3K proteins. PI3Ks are involved in
cellular trafficking, growth and death. Sex
dimorphism and pregnancy changes have been noted in
both MS and experimental autoimmune
encephalomyelitis, a commonly used animal model for
MS. These models aid in research development and
improve the understanding of immunological processes
of the disease. The studies outlined in this book
offer findings that support therapeutic advancement
for all forms of MS with a thorough investigation of
factors that guide disease susceptibility and
clinical progression.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds